Second, the Commission found that the volume-based procurement of medical devices as implemented by the GOC also significantly and recurrently impairs the access of Union operators and Union-made medical devices to the public procurement market of the PRC [See Section V of the investigation report.]. Indeed, the set-up of this volume-based procurement leads suppliers to submit extremely low bids to meet the selection criteria and win contracts, resulting in significant price reductions, which, in the long run, are unsustainable for profit-oriented companies that cannot rely on State support. The restrictive effect of this volume-based procurement system may be further enhanced by State support to producers with manufacturing and R & D activities in the PRC, particularly when this support is specifically linked to winning volume-based procurement tenders. The investigation report established that ‘the specific set-up of volume-based procurement in the PRC puts imported medical devices and foreign economic operators at a significant disadvantage and leads to de facto discrimination and restriction or even exclusion of foreign operators importing medical devices, as well as imported medical devices competing in these volume-based tenders’ [See Section V of the investigation report, p. 11.] and concluded that ‘the practical set-up of volume-based procurement of medical devices in the PRC significantly and recurrently impairs the access of Union operators and Union-made medical devices to the public procurement market of the PRC within the meaning of Article 2.1(i) of the IPI Regulation’ [See footnote 16.].
20 2. DETERMINATION OF THE IPI MEASURE › 2.1. Proportionality and adequacy of a possible IPI measure with regard to the identified measures and practices › 2.1.1. The identified measures and practices, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025